Tech Center 1600 • Art Units: 1654 1658 1675
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17293840 | METHODS AND COMPOSITIONS RELATED TO TARGETING FFAR2 AND ILC3 POPULATIONS FOR THE TREATMENT OF A GASTROINTESTINAL DISEASE | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 16972800 | Compositions of Transforming Growth Factor-Beta Type III Receptor and Uses for Ossification | Final Rejection | Emory University |
| 17597925 | ANTIMICROBIAL THERAPY THROUGH THE COMBINATION OF PORE-FORMING AGENTS AND HISTONES | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17583549 | Composition for and Method of Improving Tissue Performance | Non-Final OA | OHIO STATE INNOVATION FOUNDATION |
| 17006591 | PROTEASE SENSITIVE GVPC AND RELATED GAS VESICLE GENE CLUSTERS, EXPRESSION SYSTEMS, CONSTRUCTS, VECTORS, GENETIC CIRCUITS, CELLS, COMPOSITIONS, METHODS AND SYSTEMS FOR CONTRAST-ENHANCED IMAGING | Non-Final OA | California Institute of Technology |
| 17403357 | COMPOSITIONS COMPRISING A DELIVERY AGENT AND PREPARATION THEREOF | Final Rejection | Novo Nordisk A/S |
| 18252073 | Peptide Inhibitors of Human Mitochondrial Fission Protein 1 and Methods of Use | Non-Final OA | The Medical College of Wisconsin, Inc. |
| 18148653 | NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION | Non-Final OA | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 18044962 | PTPSIGMA-FC FUSION PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Non-Final OA | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) |
| 17263689 | METHODS AND MATERIALS FOR TREATING CANCER | Final Rejection | Board of Regents, The University of Texas System |
| 18551271 | NOVEL PEPTIDE-OLIGONUCLEOTIDE CONJUGATE AND USE THEREOF | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17619175 | TARGETING MELANOCORTIN 3 RECEPTOR FOR TREATMENT/PREVENTION OF EATING, METABOLISM, AND/OR EMOTIONAL DISORDERS | Final Rejection | The Regents of the University of Michigan |
| 16453242 | TREATMENT OF AGE RELATED MACULAR DEGENERATION WITH A SMALL ACTIVE CHOROIDAL NEOVASCULARIZATION LESION | Non-Final OA | Bayer HealthCare LLC |
| 17633631 | METHODS OF MAKING INCRETIN ANALOGS | Final Rejection | ELI LILLY AND COMPANY |
| 18664616 | SILK FIBROIN-CONTAINING COMPOSITION AND METHODS OF USE THEREOF | Non-Final OA | Georgetown University |
| 17620467 | COMPOSITES AND USES THEREOF | Non-Final OA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
| 16198019 | CARDIAC FIBROBLAST-DERIVED EXTRACELLULAR MATRIX AND INJECTABLE FORMULATIONS THEREOF FOR TREATMENT OF ISCHEMIC DISEASE OR INJURY | Final Rejection | Wisconsin Alumni Research Foundation |
| 17631072 | COMPOSITION FOR PROMOTING GROWTH OR SUPPRESSING DECREASE OF MESENCHYMAL STEM CELLS | Final Rejection | OSAKA UNIVERSITY |
| 18259092 | METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS | Non-Final OA | University of Rochester |
| 17282883 | METHODS OF REDUCING TYPE 2 CYTOKINE-MEDIATED INFLAMMATION USING NEUROMEDIN PEPTIDES | Final Rejection | Rutgers, The State University of New Jersey |
| 18731097 | PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION | Final Rejection | Prince Biotech, LLC |
| 18590539 | TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 18269716 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 17606174 | METHOD FOR PRODUCING PEPTIDE COMPOUND | Final Rejection | NISSAN CHEMICAL CORPORATION |
| 17765707 | PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN AND ITS APPENDAGES | Final Rejection | Sederma |
| 18639343 | POLYMERIC FORMS OF H-NOX PROTEINS | Final Rejection | c/o Omniox, Inc. |
| 18272549 | DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS | Non-Final OA | THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY |
| 17626625 | PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING CYCLOSPORINE | Final Rejection | PHARMATHEN S.A. |
| 17251079 | NON-VITAL WHEAT PROTEIN AND ITS PRODUCTION PROCESS | Final Rejection | ROQUETTE FRERES |
| 18612989 | PHARMACEUTICAL USE | Final Rejection | ENLITISA (SHANGHAI) PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy